After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Syndax Announces Completion of Enrollment in AUGMENT-101 Pivotal Trial Cohort of Patients with Relapsed/Refractory mNPM1 Acute Myeloid Leukemia.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Syndax Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Syndax Pharmaceuticals Inc is $1.98B. A total of 1.05 million shares were traded on the day, compared to an average of 1.21M shares.
In the most recent transaction, Morrison Briggs sold 52,855 shares of SNDX for 18.27 per share on Aug 09 ’23. After the transaction, the Director now owns 17,836 company shares. In a previous transaction on Aug 02 ’23, Meury William sold 83,000 shares at 20.46 per share. SNDX shares that Director owns now total 48,000.
Among the insiders who sold shares, Morrison Briggs disposed of 52,855 shares on Jul 10 ’23 at a per-share price of $20.40. This resulted in the Director holding 17,836 shares of SNDX after the transaction. In another insider transaction, Goldan Keith A. sold 577 shares at $22.31 per share on Jun 13 ’23. Company shares held by the Chief Financial Officer now total 2,628.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, SNDX has a high of $25.34 and a low of $11.22.
As of this writing, SNDX has an earnings estimate of -$0.99 per share for the current quarter. EPS was calculated based on a consensus of 10 estimates, with a high estimate of -$0.91 per share and a lower estimate of -$1.11. The company reported an EPS of -$0.73 in the last quarter, which was 7.60% higher than expectations of -$0.79.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. SNDX’s latest balance sheet shows that the firm has $446.83M in Cash & Short Term Investments as of fiscal 2021. There were $20.97M in debt and $20.68M in liabilities at the time. Its Book Value Per Share was $6.53, while its Total Shareholder’s Equity was $408.37M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SNDX is Buy with a score of 5.00.
